TSLA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Tesla Inc (TSLA) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has strong long-term growth potential driven by its AI and energy initiatives, the current technical indicators, financial performance, and mixed analyst ratings suggest it is better to hold off on purchasing until there is more clarity on its growth trajectory and financial recovery.
The technical indicators for TSLA are bearish. The MACD is negatively expanding, the RSI is neutral at 33.62, and the moving averages show a bearish trend (SMA_200 > SMA_20 > SMA_5). The stock is trading near its support level (S1: 369.363), with resistance levels at R1: 399.365 and R2: 408.632. The pre-market price is $369.61, down -0.66%, indicating weakness.
Analysts highlight Tesla's leadership in AI and autonomous vehicle technology, with potential growth in robotaxi services and energy solutions.
Long-term growth potential from Tesla's evolution into a multi-layered physical AI platform.
Positive sentiment around Tesla's investments in solar manufacturing and energy storage.
Financial performance in Q4 2025 showed significant declines in revenue (-3.14% YoY), net income (-63.70% YoY), and EPS (-63.64% YoY).
Analysts express skepticism about Tesla's ability to compete in the trucking market without significant investments in service and parts distribution.
Mixed analyst ratings, with some firms maintaining Sell or Underweight ratings and price targets below the current market price.
In Q4 2025, Tesla's revenue dropped to $24.9 billion (-3.14% YoY), net income fell to $840 million (-63.70% YoY), and EPS declined to $0.24 (-63.64% YoY). However, gross margin improved to 20.12%, up 23.74% YoY, indicating some operational efficiency gains.
Analyst ratings are mixed. Positive ratings include Buy ratings from Melius Research ($590 PT), BofA ($460 PT), and Tigress Financial ($550 PT), citing Tesla's leadership in AI and energy. Negative ratings include Sell ratings from UBS ($352 PT) and Underweight ratings from JPMorgan ($145 PT) and Wells Fargo ($125 PT), highlighting concerns about financial performance, high capex, and competition in key markets.
